Table 5.

Changes in residual urine volume and QT interval in the long-term analysis set.

Variable		Imidafenacin	Solifenacin
Number of subjects		11	14
Residual urine volume (mL)
0 week	(Mean ± SD)	15.1 ± 14.7	13.4 ± 11.0
4 week	(Mean ± SD)	30.9 ± 20.4*	38.6 ± 32.1**	NS
12 week	(Mean ± SD)	30.7 ± 28.0	30.6 ± 27.7*	NS
52 week	(Mean ± SD)	20.6 ± 25.4	31.1 ± 23.4**	NS
QT interval (ms)
0 week	(Mean ± SD)	413.6 ± 24.6	426.9 ± 22.4
4 week	(Mean ± SD)	415.8 ± 18.9	426.2 ± 20.1	NS
12 week	(Mean ± SD)	416.4 ± 18.4	427.2 ± 23.0	NS
52 week	(Mean ± SD)	417.0 ± 20.3	424.4 ± 22.5	NS

Intragroup (versus 0 weeks: the end of the observation period)

Paired t-test *: P < 0.05, **: P < 0.01

Intergroup: Unpaired t-test, NS: not significant, SD: standard deviation.